المؤلفون: Hans C. Ebbers, Burkhard Pieper, Amine Issa, Janet Addison, Ulrich Freudensprung, Mourad F. Rezk

المصدر: Rheumatology and Therapy, Vol 6, Iss 3, Pp 317-338 (2019)

مصطلحات موضوعية: Benepali, Biosimilar, ETN, Nocebo, Persistence, Real-world evidence, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1007/s40744-019-00169-4; https://doaj.org/toc/2198-6576; https://doaj.org/toc/2198-6584

URL الوصول: https://doaj.org/article/4f812e8ff11e4fb88be34d9ccbaedbc7

المؤلفون: Hans C. Ebbers

المصدر: Biologics, Biosimilars, and Biobetters

مصطلحات موضوعية: Risk analysis (engineering), Nocebo, business.industry, media_common.quotation_subject, Medicine, Quality (business), Real world evidence, business, Interchangeability, media_common

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::275db302a8dd4dd7a04374e642c59806
https://doi.org/10.1002/9781119564690.ch7

المؤلفون: Steven Simoens, Liese Barbier, Arnold G. Vulto, Paul Declerck, Isabelle Huys, Hans C. Ebbers

المساهمون: Pharmacy

المصدر: Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 108(4), 734-755. Wiley-Blackwell

مصطلحات موضوعية: medicine.medical_specialty, Nocebo, Reviews, Review, immunogenicity, Cross Reactions, Risk Assessment, 030226 pharmacology & pharmacy, Antibodies, law.invention, 03 medical and health sciences, Patient safety, 0302 clinical medicine, Randomized controlled trial, Risk Factors, law, substitution, Humans, Medicine, biological medicines, biosimilars, Pharmacology (medical), Intensive care medicine, Biosimilar Pharmaceuticals, Pharmacology, Biological Products, Drug Substitution, business.industry, Immunogenicity, transition, Biosimilar, anti-TNF, Discontinuation, Nocebo Effect, Treatment Outcome, 030220 oncology & carcinogenesis, Switching, Observational study, monoclonal antibodies, Patient Safety, business, interchangeability

وصف الملف: Print-Electronic; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd84e32cd6c44d214ca7fc4a0b176f8c
https://doi.org/10.1002/cpt.1836

المؤلفون: Seenu M. Hariprasad, Richard P. Gale, Christina Y. Weng, Hans C. Ebbers, Mourad F. Rezk, Ramin Tadayoni

المصدر: Ophthalmology and therapy. 11(3)

مصطلحات موضوعية: Ophthalmology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a13065a5974d6746af0bf403557ac4
https://pubmed.ncbi.nlm.nih.gov/35278204

المؤلفون: Javier P. Gisbert, Karl Gaffney, David Young, Hans C. Ebbers, Giampiero Girolomoni

مصطلحات موضوعية: Pharmacology, dermatology, Biosimilar, adalimumab, Clinical Biochemistry, Drug Discovery, rheumatology, gastroenterology, Imraldi®, SB5, anti-TNF, multidisciplinary

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e640d7724b2b84d04b966b6ec67d248
http://hdl.handle.net/11562/1059099

المؤلفون: Javier P, Gisbert, Karl, Gaffney, David, Young, Hans C, Ebbers, Giampiero, Girolomoni

المصدر: Expert opinion on biological therapy. 22(2)

مصطلحات موضوعية: Arthritis, Rheumatoid, Treatment Outcome, Adalimumab, Humans, Psoriasis, Biosimilar Pharmaceuticals

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::e16ec9b12d772cb7f3c70d23209af83c
https://pubmed.ncbi.nlm.nih.gov/34918591

المؤلفون: Juyoung Hong, Jae-Woong Hwang, Pia Høier, Shinjung Lee, Hyoung Taek Lim, Bjørn Fehrmann, Jinhan Chung, Mourad Farouk Rezk, Niels Hvorslev, Mette Ottosen, Hans C. Ebbers

المصدر: Biodrugs

مصطلحات موضوعية: Quality Control, Glycosylation, Etanercept, 03 medical and health sciences, Consistency (database systems), 0302 clinical medicine, medicine, Humans, Technology, Pharmaceutical, Pharmacology (medical), Original Research Article, Biosimilar Pharmaceuticals, Mathematics, 030203 arthritis & rheumatology, Pharmacology, Tumor Necrosis Factor-alpha, business.industry, Anti-Inflammatory Agents, Non-Steroidal, Authorization, Biosimilar, General Medicine, Infliximab, N-Acetylneuraminic Acid, Biotechnology, Europe, Antirheumatic Agents, 030220 oncology & carcinogenesis, business, Protein concentration, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d62c7efb848cbb3274dfec654025101e
https://doi.org/10.1007/s40259-019-00402-0

المؤلفون: Mourad Farouk Rezk, Burkhard Pieper, Janet Addison, Amine Issa, Hans C. Ebbers, Ulrich Freudensprung

المصدر: Rheumatology and Therapy
Rheumatology and Therapy, Vol 6, Iss 3, Pp 317-338 (2019)

مصطلحات موضوعية: medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, Nocebo, Review, Real world evidence, Etanercept, External validity, Persistence, Rheumatology, Internal medicine, medicine, Immunology and Allergy, Internal validity, Intensive care medicine, Benepali, Real-world evidence, business.industry, Biosimilar, Switch, Discontinuation, ETN, Systematic review, SB4, lcsh:RC925-935, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb930d371fac6ce6a0ab29e82a814b8
http://europepmc.org/articles/PMC6702587

المؤلفون: Paul D Chamberlain, Hans C. Ebbers

المصدر: Biodrugs

مصطلحات موضوعية: 0301 basic medicine, Internationality, Decision Making, Extrapolation, 03 medical and health sciences, 0302 clinical medicine, Drug approval, Humans, Pharmacology (medical), Biosimilar Pharmaceuticals, Drug Approval, Functional similarity, Drug Labeling, 030203 arthritis & rheumatology, Pharmacology, Drug labeling, Health professionals, Authorization, Biosimilar, General Medicine, Reference product, 030104 developmental biology, Risk analysis (engineering), Current Opinion, Drug and Narcotic Control, Business, Biotechnology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f0f01b18fadd5b35b1ffcd5ba39a90
https://doi.org/10.1007/s40259-015-0154-1

المؤلفون: Niels S. Vermeer, Hans C. Ebbers, Marie L. De Bruin, Toine C. G. Egberts, Hubert G. M. Leufkens, Sabine M. J. M. Straus

المصدر: Pharmacoepidemiology and Drug Safety. 25:297-306

مصطلحات موضوعية: Time to detection, Epidemiology, business.industry, 030204 cardiovascular system & hematology, Pharmacoepidemiology, medicine.disease, Toxicology, 03 medical and health sciences, 0302 clinical medicine, Relative risk, Spontaneous reporting, Environmental health, Pharmacovigilance, Weak association, Medicine, Pharmacology (medical), 030212 general & internal medicine, Product (category theory), business, Adverse drug reaction

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::86e1ccb9d4df670f2f32fb8da5764e5d
https://doi.org/10.1002/pds.3929

المؤلفون: Hans C Ebbers, Paul Chamberlain

المصدر: Generics and Biosimilars Initiative Journal. 3:88-93

مصطلحات موضوعية: Drug Guides, Pharmacy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cbba1055e459e2e42988b143ac09093f
https://doi.org/10.5639/gabij.2014.0302.022

المؤلفون: Huub Schellekens, Carol A. Pollock, Simon D. Roger, Gérard M. London, Nicole Casadevall, David Goldsmith, David M. Kemeny, Hans C. Ebbers, Iain C. Macdougall, Wolfgang Jelkmann, Walter H. Hörl, Angel L.M. de Francisco

المصدر: Kidney International. 81:727-732

مصطلحات موضوعية: Time Factors, Drug-Related Side Effects and Adverse Reactions, Anemia, Chemistry, Pharmaceutical, Pure red cell aplasia, Disease, Red-Cell Aplasia, Pure, Pathogenesis, Immune Tolerance, medicine, Humans, Renal Insufficiency, Chronic, Erythropoietin, biology, business.industry, Epoetin alfa, medicine.disease, anemia, clinical nephrology, Recombinant Proteins, Epoetin Alfa, pure red cell aplasia, Nephrology, Immunology, Hematinics, biology.protein, Erythropoiesis, Protein Multimerization, Antibody, business, chronic kidney disease, Kidney disease, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e271d815d42ca66d311e0067646191e
https://doi.org/10.1038/ki.2011.500

المؤلفون: Hans C. Ebbers, Hubert G. M. Leufkens, Toine Pieters, Huub Schellekens

المساهمون: Ethics, Law & Medical humanities, Other Research

المصدر: Drug Discovery Today, 17(3-4), 100-103. Elsevier Limited
Ebbers, H C, Pieters, T, Leufkens, H G & Schellekens, H 2012, ' Effective pharmaceutical regulation needs alignment with doctors ', Drug Discovery Today, vol. 17, no. 3-4, pp. 100-103 . https://doi.org/10.1016/j.drudis.2011.09.018

مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, Drug Industry, Distrust, Process (engineering), business.industry, media_common.quotation_subject, Alternative medicine, Guidelines as Topic, Biosimilar, Public relations, Europe, Physicians, Drug Discovery, medicine, Humans, Cooperative behavior, Cooperative Behavior, business, Biosimilar Pharmaceuticals, Drug Approval, Erythropoietin, media_common

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5640fbecf7923cd9974ab20a1ba4d6e0
https://doi.org/10.1016/j.drudis.2011.09.018

المؤلفون: Hans C. Ebbers, Huub Schellekens, Arnold G. Vulto, Stacy A. Crow

المساهمون: Pharmacy

المصدر: Nature Biotechnology, 30(12), 1186-1190. Nature Publishing Group

مصطلحات موضوعية: Risk Management, Therapeutic equivalency, Immunogenicity, Biomedical Engineering, Bioengineering, Biosimilar, Applied Microbiology and Biotechnology, Interchangeability, Reference product, Biosimilar Pharmaceuticals, Therapeutic Equivalency, Risk analysis (engineering), Immunology, Drug approval, Humans, Molecular Medicine, media_common.cataloged_instance, European Union, Business, European union, Drug Approval, Biotechnology, media_common

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6bc1417029d591c41dcb06378a3160
https://pure.eur.nl/en/publications/6d455331-5b4e-475d-931e-f83f5152df47

المؤلفون: Steven Simoens, Arnold G. Vulto, Isabelle Huys, Liese Barbier, Hans C. Ebbers, Paul Declerck

المصدر: Value in Health. 21:S309

مصطلحات موضوعية: 0301 basic medicine, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Risk analysis (engineering), business.industry, 030220 oncology & carcinogenesis, Health Policy, Public Health, Environmental and Occupational Health, Medicine, Biosimilar, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b19a428d0216b331a74b25ce8d17c2ee
https://doi.org/10.1016/j.jval.2018.09.1840

المؤلفون: F.A. Sayed Tabatabaei, Hans C. Ebbers, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse, Huub Schellekens, Ellen H.M. Moors

المصدر: Drug Safety. 33:891-962

مصطلحات موضوعية: Pharmacology, Data source, medicine.medical_specialty, business.industry, Biological product, Toxicology, Marketing authorization, Clinical trial, medicine, media_common.cataloged_instance, Pharmacology (medical), Pooled data, European union, Summary of Product Characteristics, Intensive care medicine, business, Less urgent, media_common

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a8143c63e32564ff80b2278ffaa6589b
https://doi.org/10.2165/11532470-000000000-00000

المؤلفون: Hans C. Ebbers

المصدر: Journal of Crohn'scolitis. 8(5)

مصطلحات موضوعية: medicine.medical_specialty, Pharmacology, Biosimilar Pharmaceuticals, Gastrointestinal Agents, Innovator, Health care, Medicine, Humans, Intensive care medicine, Evidence-Based Medicine, business.industry, Tumor Necrosis Factor-alpha, Comparability, Gastroenterology, Antibodies, Monoclonal, Biosimilar, General Medicine, Inflammatory Bowel Diseases, Infliximab, Cost savings, Clinical Practice, Europe, Treatment Outcome, Level of care, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6652aa872d54d6b3b94ee758dada9d1d
https://pubmed.ncbi.nlm.nih.gov/24594005

المؤلفون: Jacoline C. Bouvy, Huub Schellekens, Marc A. Koopmanschap, Hans C. Ebbers

المصدر: Value in Health. 16(7)

مصطلحات موضوعية: Risk analysis (engineering), Computer science, Cost effectiveness, Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327eb71dd58cf1cf09683589b2b45088

المؤلفون: Marc A. Koopmanschap, Huub Schellekens, Jacoline C. Bouvy, Hans C. Ebbers

المساهمون: Health Economics (HE)

المصدر: Clinical Pharmacology & Therapeutics, 93(5), 433-442. Wiley-Blackwell

مصطلحات موضوعية: medicine.medical_specialty, Botulinum Toxins, Cost effectiveness, Cost-Benefit Analysis, Psychological intervention, Bone Morphogenetic Protein 2, Pharmacology, law.invention, Pharmacovigilance, law, Health care, Adverse Drug Reaction Reporting Systems, Humans, Medicine, Pharmacology (medical), European Union, Intensive care medicine, Biological Products, Clinical pharmacology, business.industry, Off-Label Use, Legislation, Drug, Markov Chains, Europe, Quality-Adjusted Life Years, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e543ac2df02ed55d2d66d41ee36567
https://pure.eur.nl/en/publications/77ecffa1-a7bf-4466-91dd-44da5a39eb08

المؤلفون: Hans C. Ebbers, Huub Schellekens, Michael Muenzberg

المصدر: Expert opinion on biological therapy. 12(11)

مصطلحات موضوعية: Databases, Factual, Clinical Biochemistry, MEDLINE, Postmarketing surveillance, Pharmacology, Biopharmaceutics, Pharmacovigilance, Innovator, Recombinant Growth Hormones, Drug Discovery, Medicine, Animals, Humans, Biosimilar Pharmaceuticals, Erythropoietin, Clinical Trials as Topic, business.industry, Drug Substitution, Biosimilar, Recombinant Proteins, Clinical trial, Clinical Practice, Risk analysis (engineering), business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5291c6a311b4a379ec4b0e6cee98fa
https://pubmed.ncbi.nlm.nih.gov/22849511